A Legislative History of the Federal Food, Drug, and Cosmetic Act and Its Amendments, Volume 20U.S. Department of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1979 - Cosmetics |
Other editions - View all
Common terms and phrases
1935 death rate Actual death rate Actual deaths AXD advertising age group thou agreement American antibiotics APPLE Association basic research bill carisoprodol Cavallito Chairman Chem chemical CHUMBRIS clinical Committee companies compounds compulsory license cortisone death rate AXB Deaths at 1935 diseases DRUG INDUSTRY ANTITRUST effect erythromycin factory cost given age group granted hospital hydrocortisone INDUSTRY ANTITRUST ACT instances insulin crystals Insulin in market Insulin preparations Laboratories letters patent Licensee LILLY market packages McKesson medicine mephenesin meprobamate National NOLEN NPH Insulin patent law patent protection penicillin percent pharmaceutical industry pharmacist phenyramidol physicians Population for given prednisolone prednisone prescription product differentiation provisions public health require reserpine royalty Schedule Schering selling price Senator HART Senator HRUSKA Senator KEFAUVER sold statement steroids subcommittee substance Survivors C-E Tablets tetracycline therapeutic tion Total tuberculosis TURNER units per cc University of Toronto Upjohn
Popular passages
Page 685 - Secretary finds (1) that clinical or other experience, tests, or other scientific data show that such drug is unsafe for use under the conditions of use upon the basis of which the application was approved...
Page 690 - I. If it is not subject to the provisions of Paragraph G of this section unless its label bears (1) the common or usual name of the food, if any there be, and (2) in case it is fabricated from two or more ingredients, the common or usual name of each such ingredient...
Page 598 - ... indications, effects, dosages, routes, methods, and frequency and duration of administration, and any relevant hazards, contraindications, side effects, and precautions under which practitioners licensed by law to administer the drug can use the drug safely and for the purposes for which it is intended, including all purposes for which it is advertised or represented; and (2) If the article is subject to section 505, 506, or 507 of the act.
Page 694 - DC, then and there to testify what you may know relative to the subject matters under consideration by said committee.
Page 595 - I am taking the liberty of sending a copy of this letter to the other members of your committee.
Page 369 - DC, 20224, within the period of 30 days from the date of publication of this notice in the FEDERAL REGISTER.
Page 690 - A food shall be deemed to be misbranded — if any word, statement, or other information required by * * * this act to appear on the label * * * is not prominently placed thereon with such conspicuousness * » * and in such terms as to render it likely to be read and understood by the ordinary Individual under customary conditions of purchase and use.
Page 687 - ... the failure of the manufacturer, packer, or distributor thereof to maintain for transmittal, or to transmit, to any practitioner licensed by applicable State law to administer such drug who makes written request for information as to such drug, true and correct copies of all printed matter which is required to be included in any package in which that drug is distributed or sold, or such other printed matter as is approved by the Secretary.
Page 684 - Medical history and experience clearly demonstrate that the only possible final determination as to the efficacy and ultimate use of a drug is the extensive clinical use of that drug by large numbers of the medical profession over a long period of time.
Page 364 - District, and of the American Public Health Association, the American Association for the Advancement of Science, and the American Archaeological and Numismatic Society.